Money, Mary E.

Mary E. Money is a clinical research entity and medical practice led by Dr. Mary E. Money, a board-certified internist based in Hagerstown, Maryland. The entity is primarily known for conducting investigator-initiated clinical trials focused on gastroenterology and internal medicine. Dr. Money's most significant contribution to the field is her research into the repurposing of ondansetron, a 5-HT3 receptor antagonist, for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D). Her work has been published in major medical journals and has influenced clinical guidelines for IBS management. The practice collaborates with academic institutions and pharmaceutical companies to advance patient care through evidence-based research. It serves as a model for community-based clinical investigation.